FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3764411000001107: Lidocaine 2% gel 15 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21809701000001113 Lidocaine 2% gel 15 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21809801000001116 Lidocaine 2% gel 15 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 2% gel 15 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Is pack of Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has VMP Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Lidocaine 2% gel 15 ml VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lidocaine 2% gel (A A H Pharmaceuticals Ltd) 15 ml Is a True Lidocaine 2% gel 15 ml Inferred relationship Existential restriction modifier
Lidocaine 2% gel (AstraZeneca) 15 ml Is a True Lidocaine 2% gel 15 ml Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Unichem Plc) 15 ml Is a True Lidocaine 2% gel 15 ml Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Approved Prescription Services) 15 ml Is a True Lidocaine 2% gel 15 ml Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Drug Tariff Special Order) 15 ml Is a True Lidocaine 2% gel 15 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start